Studying the Use of qCONqNOX-Guided Anesthesia with the Conox Monitor to Improve Outcomes in Thyroid Surgery Patients

What this Trial Is About

Researchers are evaluating the use of the non-invasive Conox monitor during thyroidectomy surgery to see how it affects opioid use during the operation. The study also examines its impact on recovery time, postoperative agitation, and pain levels. Additionally, it explores how the qCON and qNOX values from this device relate to traditional heart rate and blood pressure measurements. Participants receive anesthesia induction with propofol, fentanyl, and rocuronium, followed by maintenance with sevoflurane and remifentanil. In the Conox group, anesthesia depth and pain response are guided by EEG-based qCON and qNOX values to adjust drug dosing. The control group follows standard care using heart rate and blood pressure to guide opioid use. Measurements include opioid consumption, recovery times, agitation, and pain scores. During the study, participants will have opioid use and recovery monitored closely, including pain assessments every five minutes in the post-anesthesia care unit. Researchers will also record extubation times and agitation scores. The study aims to compare clinical outcomes between groups and assess correlations between EEG monitoring and traditional hemodynamic parameters, with the overall goal of improving anesthesia management in thyroid surgery.

qCON/qNOX-Guided Anesthesia in Patients Undergoing Thyroidectomy Surgery